Agilent Technologies, Inc. $A Stock Holdings Increased by Louisbourg Investments Inc.

Louisbourg Investments Inc. increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 29.3% in the 1st quarter, HoldingsChannel.com reports. The firm owned 46,369 shares of the medical research company’s stock after buying an additional 10,495 shares during the quarter. Louisbourg Investments Inc.’s holdings in Agilent Technologies were worth $5,285,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA increased its stake in Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after buying an additional 1,713,216 shares during the period. State Street Corp boosted its stake in shares of Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after buying an additional 241,029 shares during the period. Wellington Management Group LLP grew its holdings in shares of Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after acquiring an additional 433,342 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Finally, Morgan Stanley increased its stake in shares of Agilent Technologies by 15.9% in the fourth quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after acquiring an additional 692,202 shares during the last quarter.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent completed its acquisition of Biocare Medical, strengthening its diagnostics and clinical pathology offerings and potentially improving long-term growth prospects. Agilent finalizes Biocare Medical takeover
• Positive Sentiment: Sanford C. Bernstein initiated coverage with an outperform rating and a $155 price target, which may bolster investor confidence in additional share price upside. Benzinga coverage
• Positive Sentiment: Recent commentary highlights Agilent’s post-earnings resilience, reflecting steady investor interest after the company beat expectations and raised/confirmed guidance. Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
• Neutral Sentiment: Piper Sandler initiated coverage at Neutral with a $150 target, which is supportive but less bullish than Bernstein’s call. Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
• Neutral Sentiment: Articles about dividend reliability and broader adoption of Agilent software suggest steady fundamentals, but they are less likely to drive a major near-term stock move. Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? Shanghai ICRD Adopts Agilent Software
• Neutral Sentiment: Agilent’s stock has been trading with modest strength following the earnings release, but the move appears tied more to execution and sentiment than to any single dramatic catalyst. Agilent (A) stock trades up, here is why

Wall Street Analyst Weigh In

Several brokerages recently issued reports on A. Royal Bank Of Canada initiated coverage on Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective for the company. Wells Fargo & Company dropped their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, May 28th. HSBC cut their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Piper Sandler started coverage on Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Finally, TD Cowen boosted their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average target price of $160.88.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $136.29 on Friday. The company has a market cap of $38.49 billion, a price-to-earnings ratio of 27.37, a PEG ratio of 2.42 and a beta of 1.26. The business has a 50 day moving average price of $122.86 and a 200 day moving average price of $126.32. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the company earned $1.31 earnings per share. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.